|
|
|
Volumn , Issue SPEC. ISS. JUN., 2000, Pages 8-9
|
|
Anti-aldosterone: The evidences of the RALES study;Anti-aldosterone: Les preuves de l'etude RALES
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALDOSTERONE ANTAGONIST;
DIGOXIN;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
LOOP DIURETIC AGENT;
SPIRONOLACTONE;
BIOLOGICAL MARKER;
DIURETIC AGENT;
PROCOLLAGEN;
CLINICAL TRIAL;
CONFERENCE PAPER;
DISEASE SEVERITY;
DIURETIC THERAPY;
DRUG EFFICACY;
HEART EJECTION FRACTION;
HEART FAILURE;
HUMAN;
MORTALITY;
RISK MANAGEMENT;
ARTICLE;
CONTROLLED CLINICAL TRIAL;
FORWARD HEART FAILURE;
HEART MUSCLE FIBROSIS;
HOSPITALIZATION;
RANDOMIZED CONTROLLED TRIAL;
RISK FACTOR;
SURVIVAL RATE;
ALDOSTERONE ANTAGONISTS;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
BIOLOGICAL MARKERS;
CARDIAC OUTPUT, LOW;
DIURETICS;
ENDOMYOCARDIAL FIBROSIS;
HOSPITALIZATION;
HUMANS;
PROCOLLAGEN;
RANDOMIZED CONTROLLED TRIALS;
RISK FACTORS;
SPIRONOLACTONE;
SURVIVAL RATE;
|
|
EID: 0034198677
PISSN: 1261694X
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (1)
|
|
References (0)
|